Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin

por Pant, Alok, Lee, Irene I., Lu, Zhenxiao, Rueda, Bo R., Schink, Julian, Kim, J. Julie
Publicado 2012

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer

por Chen, Siqi, Xie, Ping, Cowan, Matthew, Huang, Hao, Cardenas, Horacio, Keathley, Russell, Tanner, Edward J., Fleming, Gini F., Moroney, John W., Pant, Alok, Akasha, Azza M., Davuluri, Ramana V., Kocherginsky, Masha, Zhang, Bin, Matei, Daniela
Publicado 2022